Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (2722)	11/11/1997 4:16:00 PM
From: Steve Fancy	Read Replies (1) \| Respond to of 6136

Izzy...tough to tell. There are a lot of great bargains out there right now, AGPH certainly among them. This nervousness over Asian concerns seems overblown to me. My guess (hope) is that we have a much better week across the board, starting with tomorrow. All the confident investors seem to have gone on vacation, leaving those with fear behind to battle it out for a couple of days. Quite often after these vacations we see a nice rally. With AGPH there must be some news circulating to cause an almost 3 point drop today. Could be an opportunity, sure seems like it, but I for one am already holding too much. sf

To: Izzy who wrote (2722)	11/11/1997 5:51:00 PM
From: Joe E.	Respond to of 6136

<<Just bought more at 41 1/4. Do I assume that you all agree that this is a cheap price for AGPH and it's rather unlikely that the price is going lower? After all, this is 82+ pre-split, which would have been a bargain. The price is still about 15 off from it's high. Any ideas out there?>> I think that is a very good price, about 25% under fair value, by my calcs. Is there maybe some news out of one of the medical conferences underway now that impacts AGPH? It would have to be an impact on one of the development stage drugs, I guess. The alternative read (probably most correct) is Fortovase, which would be a misread of the market for protease inhibitors. I took the opportunity to uncover some covered calls, so I agree this is a buying opportunity.